Metraipolis › archive › dc_ff9ad4ebe197

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PMID:42125459

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42125459
DOI: 10.3389/fpsyt.2026.1823912
License (as archived): solo-consultazione
Archived: 2026-10-08T05:38:51.255Z
SHA-256 of the archived text: 375089b7773309a3e9f21e0b26485a97a5a818da3efa998adc64d961f0d7b246
Stable URL of this page: https://metraipolis.com/documento/dc_ff9ad4ebe197

How to cite

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PMID:42125459 — Europe PMC (en), https://europepmc.org/article/MED/42125459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff9ad4ebe197 (Metraipolis archive dc_ff9ad4ebe197, sha256 375089b7773309a3e9f21e0b26485a97a5a818da3efa998adc64d961f0d7b246)

BibTeX

@misc{dcff9ad4ebe197,
  title = {Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PMID:42125459},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125459},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff9ad4ebe197; sha256 375089b7773309a3e9f21e0b26485a97a5a818da3efa998adc64d961f0d7b246},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125459. Agents can read the archived copy with the MCP tool read_document.